Skip to content
GLP-1 Savers
Menu
Ranked #406 · Watch List

Zealthy review

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $286/mo

Save ~79% vs brand-name

From $286/mo (starting dose, plus a separate fee, compounded)

FDA warning letter. The FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025. Check it on the FDA database.

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose, and the price is not shown until after you complete an intake.

How much does Zealthy cost?

The price Zealthy publishes is From $286/mo (starting dose, plus a separate fee, compounded). Tirzepatide is listed at From $351/mo (starting dose, plus a separate fee, compounded). We flag this one to watch: confirm the ongoing rate with Zealthy before you count on it, because a low first month can step up afterward. That works out about 79% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
From $351/mo (starting dose, plus a separate fee, compounded)
Coverage
34 states
Brand-name
Compounded only

The Value Score card

Zealthy scored on our six published factors. See the methodology.

Lowest Real Price55/100
No Teaser-Rate Bait30/100
Nationwide Availability72/100
Both Molecules92/100
Easy Cancellation54/100
Reputation25/100

Why it's a deal

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Read the fine print

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers who want not currently recommended — listed for transparency and reader awareness only. Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

Ranked #406 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Zealthy, out of 426 others we track.

Shopping Zealthy against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Zealthy, and every program that undercuts or outscores it — starting with Remedy Meds, the closest match on score — is ranked on the Zealthy alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Zealthy's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals